Are there disadvantages in administering 131I ablation therapy in patients with differentiated thyroid carcinoma without a preablative diagnostic 131I whole‐body …
M Salvatori, G Perotti, V Rufini… - Clinical …, 2004 - Wiley Online Library
Summary objective To evaluate the risk of performing inappropriate 131I ablative therapies
for thyroid carcinoma in patients lacking thyroid remnants or metastases, using a strategy of …
for thyroid carcinoma in patients lacking thyroid remnants or metastases, using a strategy of …
The role of routine diagnostic radioiodine whole-body scintigraphy in patients with high-risk differentiated thyroid cancer
SG de Meer, MR Vriens, PM Zelissen… - Journal of Nuclear …, 2011 - Soc Nuclear Med
Follow-up diagnostic radioiodine whole-body scintigraphy (DxWBS) is still advised for high-
risk patients with differentiated thyroid cancer. The aim of this study was to evaluate the …
risk patients with differentiated thyroid cancer. The aim of this study was to evaluate the …
[HTML][HTML] Postoperative thyroglobulin as a yard-stick for radioiodine therapy: decision tree analysis in a European multicenter series of 1317 patients with differentiated …
Purpose An accurate postoperative assessment is pivotal to inform postoperative 131I
treatment in patients with differentiated thyroid cancer (DTC). We developed a predictive …
treatment in patients with differentiated thyroid cancer (DTC). We developed a predictive …
[HTML][HTML] Prognostic factors and the effect of radioiodine on patients with locally advanced differentiated thyroid cancer
Y Yao, S Cheng, X Xu, X Chen, W Chen… - Annals of …, 2020 - ncbi.nlm.nih.gov
Background Locally advanced differentiated thyroid cancer (DTC) is rare. The optimal
treatment remains controversial. This study was to investigate the natural history and …
treatment remains controversial. This study was to investigate the natural history and …
Prognostic implication of thyroglobulin and quantified whole body scan after initial radioiodine therapy on early prediction of ablation and clinical response for the …
Objective To investigate predictors for successful ablation and disease-free status after high-
dose radioiodine therapy in patients with differentiated thyroid cancer. Methods We enrolled …
dose radioiodine therapy in patients with differentiated thyroid cancer. Methods We enrolled …
Patients with high‐risk differentiated thyroid cancer have a lower I‐131 ablation success rate than low‐risk ones in spite of a high ablation activity
J Winter, M Winter, T Krohn, A Heinzel… - Clinical …, 2016 - Wiley Online Library
Objective To examine success rates in strictly defined high‐risk differentiated thyroid cancer
(DTC) patients who received a high‐activity (≥ 5550 MB q) adjuvant postoperative I‐131 …
(DTC) patients who received a high‐activity (≥ 5550 MB q) adjuvant postoperative I‐131 …
No survival difference after successful 131I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer
FA Verburg, MPM Stokkel, C Düren… - European journal of …, 2010 - Springer
Purpose To compare disease-specific survival and recurrence-free survival (RFS) after
successful 131 I ablation in patients with differentiated thyroid carcinoma (DTC) between …
successful 131 I ablation in patients with differentiated thyroid carcinoma (DTC) between …
Dynamic risk stratification in patients with differentiated thyroid cancer treated without radioactive iodine
DP Momesso, F Vaisman, SP Yang… - The Journal of …, 2016 - academic.oup.com
Context: Although response to therapy assessment is a validated tool for dynamic risk
stratification in patients with differentiated thyroid cancer (DTC) treated with total …
stratification in patients with differentiated thyroid cancer (DTC) treated with total …
[HTML][HTML] The role of Hashimoto thyroiditis in predicting radioiodine ablation efficacy and prognosis of low to intermediate risk differentiated thyroid cancer
D Albano, F Dondi, V Zilioli, MB Panarotto… - Annals of nuclear …, 2021 - Springer
Objective The baseline treatment of differentiated thyroid cancer (DTC) consists of
thyroidectomy followed by postoperative risk-adapted radioiodine therapy (RAIT) when …
thyroidectomy followed by postoperative risk-adapted radioiodine therapy (RAIT) when …
[HTML][HTML] Low-dose radioiodine ablation in patients with low-risk differentiated thyroid cancer
GAJ Londoño, AMG Vicente, JS Marcos… - European Thyroid …, 2018 - etj.bioscientifica.com
Aim: Based on the response criteria of the 2015 American Thyroid Associations guidelines,
our objectives were to determine the response rate when using a low dose of 131-I GBq in …
our objectives were to determine the response rate when using a low dose of 131-I GBq in …